Serum adiponectin is associated with worsened overall survival in a prospective cohort of hepatocellular carcinoma patients.
Siegel AB, Goyal A, Salomao M, Wang S, Lee V, Hsu C, Rodriguez R, Hershman DL, Brown RS Jr, Neugut AI, Emond J, Kato T, Samstein B, Faleck D, Karagozian R.
Siegel AB, et al. Among authors: salomao m.
Oncology. 2015;88(1):57-68. doi: 10.1159/000367971. Epub 2014 Oct 3.
Oncology. 2015.
PMID: 25300295
Free PMC article.